Market Tracker

09/01 6:05pm ET

Echo Therapeutics Inc (NASDAQ:ECTE)

1.86
Data as of Aug 29
 +0.01 / +0.54%
Today’s Change
1.53
Today|||52-Week Range
4.91
-40.76%
Year-to-Date

Today’s Trading

Previous close1.85
Today’s open1.85
Day’s range1.83 - 1.87
Volume15,488
Average volume (3 months)46,909
Market cap$23.6M
Dividend yield--
Data as of 3:59pm ET, 08/29/2014

Growth & Valuation

Earnings growth (last year)+24.84%
Earnings growth (this year)+59.66%
Earnings growth (next 5 years)+40.00%
Revenue growth (last year)+439.17%
P/E ratioNM
Price/Sales951.08
Price/Book1.13

Competitors

 Today’s
change
Today’s
% change
CTRVContraVir Pharmaceut...-0.09-6.52%
CBLICleveland Biolabs In...-0.02-5.86%
DARADARA BioSciences Inc-0.01-1.19%
RTGNRuthigen Inc+0.14+2.77%
Data as of 3:59pm ET, 08/29/2014

Financials

Next reporting dateNovember 6, 2014
EPS forecast (this quarter)-$0.20
Annual revenue (last year)$27.6K
Annual profit (last year)-$19.1M
Net profit margin-69,084.77%

Profile

Sector
Health Technology
Industry
Medical Specialties
CEO, Secretary, Chief Compliance Officer &
SVP
Kimberly A. Burke
Senior Vice President-
Operations
Marshall D. Deweese
Corporate headquarters
Philadelphia, Pennsylvania

Forecasts